150 related articles for article (PubMed ID: 25109259)
1. Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome.
El-Salhy M; Gilja OH; Hausken T
Mol Med Rep; 2014 Oct; 10(4):1753-7. PubMed ID: 25109259
[TBL] [Abstract][Full Text] [Related]
2. Stomach antral endocrine cells in patients with irritable bowel syndrome.
El-Salhy M; Gilja OH; Hatlebakk JG; Hausken T
Int J Mol Med; 2014 Oct; 34(4):967-74. PubMed ID: 25110039
[TBL] [Abstract][Full Text] [Related]
3. Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities.
El-Salhy M; Hatlebakk JG; Hausken T
World J Gastroenterol; 2015 Aug; 21(32):9577-87. PubMed ID: 26327765
[TBL] [Abstract][Full Text] [Related]
4. Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome.
El-Salhy M; Wendelbo IH; Gundersen D
Mol Med Rep; 2013 Apr; 7(4):1241-4. PubMed ID: 23426642
[TBL] [Abstract][Full Text] [Related]
5. Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome.
Mazzawi T; Gundersen D; Hausken T; El-Salhy M
Mol Med Rep; 2014 Nov; 10(5):2322-6. PubMed ID: 25174455
[TBL] [Abstract][Full Text] [Related]
6. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome.
El-Salhy M; Mazzawi T; Gundersen D; Hausken T
Mol Med Rep; 2012 Dec; 6(6):1223-5. PubMed ID: 22992886
[TBL] [Abstract][Full Text] [Related]
7. Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance.
Mazzawi T; El-Salhy M
Int J Mol Med; 2016 May; 37(5):1247-53. PubMed ID: 26987104
[TBL] [Abstract][Full Text] [Related]
8. Abnormal rectal endocrine cells in patients with irritable bowel syndrome.
El-Salhy M; Gundersen D; Hatlebakk JG; Gilja OH; Hausken T
Regul Pept; 2014 Jan; 188():60-5. PubMed ID: 24316398
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome.
El-Salhy M; Gilja OH
BMC Gastroenterol; 2017 Aug; 17(1):90. PubMed ID: 28764761
[TBL] [Abstract][Full Text] [Related]
10. Endocrine cells in the ileum of patients with irritable bowel syndrome.
El-Salhy M; Gilja OH; Gundersen D; Hatlebakk JG; Hausken T
World J Gastroenterol; 2014 Mar; 20(9):2383-91. PubMed ID: 24605036
[TBL] [Abstract][Full Text] [Related]
11. Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome.
El-Salhy M; Lomholt-Beck B; Hausken T
Scand J Gastroenterol; 2010 Dec; 45(12):1435-9. PubMed ID: 20602602
[TBL] [Abstract][Full Text] [Related]
12. Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome.
El-Salhy M; Gilja OH; Gundersen D; Hausken T
World J Gastrointest Endosc; 2014 May; 6(5):176-85. PubMed ID: 24891930
[TBL] [Abstract][Full Text] [Related]
13. Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome.
El-Salhy M; Patcharatrakul T; Hatlebakk JG; Hausken T; Gilja OH; Gonlachanvit S
Scand J Gastroenterol; 2017; 52(6-7):691-697. PubMed ID: 28346031
[TBL] [Abstract][Full Text] [Related]
14. Density of Musashi‑1‑positive stem cells in the stomach of patients with irritable bowel syndrome.
El-Salhy M; Hausken T; Hatlebakk JG
Mol Med Rep; 2020 Oct; 22(4):3135-3140. PubMed ID: 32945509
[TBL] [Abstract][Full Text] [Related]
15. Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome.
El-Salhy M; Vaali K; Dizdar V; Hausken T
Dig Dis Sci; 2010 Dec; 55(12):3508-13. PubMed ID: 20300845
[TBL] [Abstract][Full Text] [Related]
16. Increased serotonin transporter immunoreactivity intensity in the ileum of patients with irritable bowel disease.
Wendelbo I; Mazzawi T; El-Salhy M
Mol Med Rep; 2014 Jan; 9(1):180-4. PubMed ID: 24213511
[TBL] [Abstract][Full Text] [Related]
17. Serotonin and serotonin transporter in the rectum of patients with irritable bowel disease.
El-Salhy M; Wendelbo I; Gundersen D
Mol Med Rep; 2013 Aug; 8(2):451-5. PubMed ID: 23778763
[TBL] [Abstract][Full Text] [Related]
18. Effect of dietary management on the gastric endocrine cells in patients with irritable bowel syndrome.
Mazzawi T; Hausken T; Gundersen D; El-Salhy M
Eur J Clin Nutr; 2015 Apr; 69(4):519-24. PubMed ID: 25097003
[TBL] [Abstract][Full Text] [Related]
19. Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance.
Mazzawi T; El-Salhy M
Exp Biol Med (Maywood); 2017 Jul; 242(13):1355-1362. PubMed ID: 28737477
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin in patients with irritable bowel syndrome.
El-Salhy M; Lillebø E; Reinemo A; Salmelid L
Int J Mol Med; 2009 Jun; 23(6):703-7. PubMed ID: 19424595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
